Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04739397 · ClinicalTrials.gov registry record
Evaluation of the EpiGlare Tester for the Measurement of Glare-Induced Changes in BSCVA in Subjects With and Without Cataracts
A clinical trial of Cataract, sponsored by Epico.
- Completed
- Registry status
- 89
- Enrollment target
- 1
- Study location
NCT04739397 is a study of Cataract that has completed, run by Epico. The registered enrollment target is 89 participants, below the 227-participant average among 83 other Cataract trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04739397, a study of Cataract, has completed, sponsored by Epico.
- COMPLETED
- Registry status
- 89 participants
- Enrollment target
- 1
- Study location
Study Summary
The EpiGlare Tester will identify visual disability resulting from the glare experienced by subjects with cataracts in the glare-induced change in best spectacle corrected visual acuity (BSCVA).
Conditions Studied
Interventions
- DEVICE Glare Testing
Study Locations (1)
Ohio
- The Eye Center of Columbus - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2011-11 |
| Est. Completion | 2013-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04739397
The ClinicalTrials.gov registry entry for NCT04739397 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 227-participant average among 83 other Cataract trials with a reported enrollment target (61% lower). The listed sponsor is Epico, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cataract appearing as the primary indexed condition, and to 1 intervention - of which Glare Testing is the first listed.
NCT04739397 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT04739397 about?
NCT04739397 is a clinical study titled "Evaluation of the EpiGlare Tester for the Measurement of Glare-Induced Changes in BSCVA in Subjects With and Without Cataracts". The EpiGlare Tester will identify visual disability resulting from the glare experienced by subjects with cataracts in the glare-induced change in best spectacle corrected visual acuity (BSCVA).
What is the current status of trial NCT04739397?
This trial is currently completed. The enrollment target is 89 participants. The study started on 2011-11. Estimated completion is 2013-06.
What conditions does trial NCT04739397 study?
This clinical trial studies the following conditions: Cataract.
What interventions are being tested in trial NCT04739397?
The interventions under investigation include: Glare Testing (DEVICE).
Who is sponsoring clinical trial NCT04739397?
This trial is sponsored by Epico, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04739397 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Intraocular Lens Power Calculation After Laser Refractive Surgery Based on Optical Coherence Tomography
RECRUITING
-
Effective Phaco Time and Endothelial Cell Loss When Using Veritas
RECRUITING
-
Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety and Workflow Study
RECRUITING · NA
-
Study of Complication Rates in Cataract Surgery Patients Treated With Combined Pre-operative NSAID, OMIDRIA, and Subconjunctival Triamcinolone Acetonide Compared With Peri-operative SOC
RECRUITING · Phase 1
-
A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)
RECRUITING · Phase 3
-
Unity VCS: A Comparison Study Evaluating Corneal Clarity and Thickness
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.